2 results match your criteria: "The Hospital for Sick Children (SickKids) and University of Toronto[Affiliation]"
A Comparison of International League of Associations for Rheumatology and Pediatric Rheumatology International Trials Organization Classification Systems for Juvenile Idiopathic Arthritis Among Children in a Canadian Arthritis Cohort.
Arthritis Rheumatol
August 2022
The Hospital for Sick Children (SickKids) and University of Toronto, Toronto, Ontario, Canada.
Objective: The aim of the Paediatric Rheumatology International Trials Organisation (PRINTO) juvenile idiopathic arthritis (JIA) classification criteria, which is still in development, is to identify homogeneous groups of JIA patients. This study was undertaken to compare International League of Associations for Rheumatology (ILAR) JIA classification criteria and PRINTO JIA classification criteria using data from the ReACCh-Out (Research in Arthritis in Canadian Children, Emphasizing Outcomes) cohort.
Methods: We used clinicobiologic data recorded within 7 months of diagnosis to assign a diagnosis of JIA and identify subcategories of JIA among 1,228 patients according to the 2 JIA classification systems.
Effect of moist heat reprocessing of N95 respirators on SARS-CoV-2 inactivation and respirator function.
CMAJ
October 2020
SickKids Research Institute (Daeschler, Chan, Tajdaran, Mirmoeini, Darbandi), The Hospital for Sick Children (SickKids); The Hospital for Sick Children (SickKids) Occupational Health and Safety (Manson); Division of Plastic and Reconstructive Surgery (Joachim, J. Zhang), The Hospital for Sick Children (SickKids) and University of Toronto, Toronto, Ont.; School of Public Health, LKS Faculty of Medicine (Chin, Poon), The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China; Chemical Engineering & Applied Chemistry (Chen, Gu), University of Toronto; Department of Anesthesia and Pain Medicine (Maynes, L. Zhang) and Division of Infectious Disease (Science), and Child Health Evaluative Sciences (Stephens), and Institute of Biomaterials and Biomedical Engineering and Division of Plastic and Reconstructive Surgery (Borschel), The Hospital for Sick Children, Toronto, Ont.
Background: Unprecedented demand for N95 respirators during the coronavirus disease 2019 (COVID-19) pandemic has led to a global shortage of these masks. We validated a rapidly applicable, low-cost decontamination protocol in compliance with regulatory standards to enable the safe reuse of N95 respirators.
Methods: We inoculated 4 common models of N95 respirators with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and evaluated viral inactivation after disinfection for 60 minutes at 70°C and 0% relative humidity.